402 results on '"Sperling, Rhoda"'
Search Results
2. Prevalence, Risk Profiles, and National Implications of Nonalcoholic Fatty Liver Disease in Pregnant Individuals
3. Distinct cord blood C-peptide, adipokine, and lipidomic signatures by in utero HIV exposure
4. Treatment of Women With Hepatitis C Diagnosed in Pregnancy: a Co-Located Treatment Approach
5. 62 Unraveling the role of placental trophoblast cells in preeclampsia
6. Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol.
7. Abstract 14077: Human Placental CDX2 Cells Are Multipotent and Differentiate Robustly to Cardiomyocytes
8. Expression quantitative trait locus fine mapping of the 17q12–21 asthma locus in African American children: a genetic association and gene expression study
9. Knowledge of the Relationship Between Breastfeeding and Breast Cancer Risk Among Racial and Ethnic Minority Women
10. Obstetrics and Gynecology
11. Innate immune activation and depressive and anxious symptoms across the peripartum: An exploratory study
12. Neurodevelopment of HIV-Exposed Uninfected Infants Born to Women with Perinatally-Acquired HIV in the United States
13. Development of a High-Throughput Assay To Measure the Neutralization Capability of Anti-Cytomegalovirus Antibodies
14. Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol
15. Discovery of a multipotent cell type from the term human placenta
16. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Titer Levels in Pregnant Individuals After Infection, Vaccination, or Both
17. Infections in pregnancy
18. Safety and Efficacy of Sofosbuvir/Velpatasvir for the Treatment of Hepatitis C in Reproductive Aged Women [28J]
19. Impact of prenatal COVID-19 vaccination on delivery and neonatal outcomes: Results from a New York City cohort
20. High prevalence of HPV59 in cytologically abnormal cervical samples
21. Low vitamin D status among pregnant Latin American and Caribbean women with HIV Infection
22. Unique Profile of Inflammation and Immune Activation in Pregnant People With HIV in the United States
23. Prevalence of elevated alanine aminotransferase (ALT) in pregnancy: A cross-sectional labor and delivery-based assessment
24. Influenza Vaccination, Pregnancy Safety, and Risk of Early Pregnancy Loss
25. Establishing a protocol for management and DAA treatment of HCV during pregnancy: adherence to a co-located care protocol
26. Pregnancy as a unique opportunity to identify NAFLD in women: a prospective assessment
27. Influence of pregnancy on NAFLD-associated lipidomic signatures
28. Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: A pilot study
29. Lower mitochondrial DNA and altered mitochondrial fuel metabolism in HIV-exposed uninfected infants in Cameroon
30. 211: OUTCOMES IN INFANTS BORN TO MOTHERS WITH AND WITHOUT NON-ALCOHOLIC FATTY LIVER DISEASE
31. Sa1542 PREDICTORS OF LIVER INJURY IN THE CONTEXT OF HYPERTENSIVE DISORDERS OF PREGNANCY AMONG INDIVIDUALS WITH AND WITHOUT MASLD
32. The Effect of Daily Valacyclovir Suppression on Herpes Simplex Virus Type 2 Viral Shedding in HSV-2 Seropositive Subjects Without a History of Genital Herpes
33. Maternal cytokine response after SARS-CoV-2 infection during pregnancy
34. Impact of Prenatal COVID-19 Vaccination on Delivery and Neonatal Outcomes: Results from a New York City Cohort
35. SARS‐CoV‐2 during pregnancy and associated outcomes: Results from an ongoing prospective cohort
36. Lower Preprandial Insulin and Altered Fuel Use in HIV/Antiretroviral-Exposed Infants in Cameroon
37. Growth patterns in the first year of life differ in infants born to perinatally vs. nonperinatally HIV-infected women
38. Parental characteristics, somatic fetal growth, and season of birth influence innate and adaptive cord blood cytokine responses
39. Distinct cord blood C-peptide, adipokine, and lipidomic signatures by in utero HIV exposure
40. Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus Type 1-Infected Pregnant Women and Their Neonates
41. Maternal Viral Genotypic Zidovudine Resistance and Infrequent Failure of Zidovudine Therapy to Prevent Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Pediatric AIDS Clinical Trials Group Protocol 076
42. The influence of pregnancy on systemic immunity
43. Characterizing the Pregnancy Immune Phenotype: Results of the Viral Immunity and Pregnancy (VIP) Study
44. Corrigendum to: Hepatitis C Seroprevalence Among Consecutive Labor and Delivery Admissions in Two New York City Hospitals
45. 95 EVALUATION OF ADHERENCE TO THE CASCADE OF CARE FOR ABNORMAL LIVER TEST MANAGEMENT DURING PREGNANCY
46. SARS‐CoV‐2 during pregnancy and associated outcomes: Results from an ongoing prospective cohort.
47. Seroprevalence of SARS-CoV-2 during pregnancy and associated outcomes: results from an ongoing prospective cohort study, New York City
48. Microbiologic Etiology and Infant Factors Associated with Early Onset Neonatal Bacteremia at the Mount Sinai Hospital
49. Gestational Diabetes Mellitus in HIV-Infected and -Uninfected Pregnant Women in Cameroon
50. Selective COX-2 inhibition and cardiovascular effects: A review of the refecoxib development program
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.